GC WellBeing Corporation (KOSDAQ:234690)
8,250.00
+990.00 (13.64%)
At close: Jun 29, 2026
GC WellBeing Market Cap
GC WellBeing has a market cap or net worth of 142.75 billion as of June 30, 2026. Its market cap has decreased by -19.55% in one year.
Market Cap
142.75B
Enterprise Value
220.90B
Revenue
179.05B
Ranking
n/a
PE Ratio
75.57
Stock Price
8,250.00
Market Cap Chart
Since October 14, 2019, GC WellBeing's market cap has decreased from 221.90B to 142.75B, a decrease of -35.67%. That is a compound annual growth rate of -6.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 142.75B | -11.99% |
| Dec 30, 2025 | 162.19B | -9.18% |
| Dec 30, 2024 | 178.59B | 23.74% |
| Dec 28, 2023 | 144.33B | -1.22% |
| Dec 29, 2022 | 146.10B | -18.92% |
| Dec 30, 2021 | 180.19B | -27.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellBion | 192.29B |
| DAE HWA Pharmaceutical | 153.62B |
| Vivozon Pharmaceutical | 149.81B |
| High Tech Pharm | 135.15B |
| PHARMARESEARCH BIO | 129.18B |
| Kyung Dong Pharmaceutical | 127.17B |
| Cosmax Nbt | 116.13B |
| Ahn-Gook Pharmaceutical | 106.72B |